QT Sense
Latest round
- Seed
Last raised
- Jan 2026
Total raised
- $3.5M
Investors
- 2
About QT Sense
QT Sense focuses on advancing quantum sensing technology, particularly in biomedical applications, by creating innovative products that enhance the understanding of cellular dynamics. QT Sense was founded in 2024 in Groningen, Netherlands, specializing in quantum sensing technology. The company was established to develop products for real-time monitoring of oxidative stress at the cellular level. The founder has a history of entrepreneurial ventures, although specific details of previous companies are not available.V. QT Sense specializes in advanced quantum sensing technology, with its flagship product, the Quantum Nuova. This device is designed for real-time monitoring of oxidative stress at the cellular level, utilizing diamond-based magnetometry to measure free radicals with nanoscale precision. The technology has been particularly useful in biomedical research, addressing critical health conditions linked to oxidative stress, such as cancer, male fertility, and arthritis. Customers include academic research institutions and medical facilities, primarily in North America and Europe, where the product has been implemented in studies to assess drug efficacy, investigate cellular responses, and differentiate between types of arthritis. The Quantum Nuova offers a non-invasive approach, enabling researchers to gain insights into cellular dynamics without compromising cell viability, thus facilitating advancements in various therapeutic areas. The revenue model for QT Sense is structured around direct sales of the Quantum Nuova and its optional components, which enhance the core system’s capabilities for specific applications. Clients typically engage in purchasing the device outright and may also take advantage of leasing options, allowing for a minimum 12-month commitment. Transactions are primarily conducted in a B2B environment, targeting universities, research centers, and pharmaceutical companies. The pricing structure includes the base unit of the Quantum Nuova, with further customization available through optional accessories and consumables, which are essential for conducting experiments. This transactional framework supports a steady revenue stream, allowing QT Sense to expand its customer base while contributing to ongoing research and development efforts in the field of quantum sensing and biomedical applications.
Who invested in QT Sense
2 investors across 1 round
See all investors in QT Sense
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 4, 2026
Amount
$3.5M
Investors
Questions about QT Sense
Who invested in QT Sense?
QT Sense has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has QT Sense raised?
QT Sense has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did QT Sense last raise money?
QT Sense's most recent round on record is a Seed, in Jan 2026.
What does QT Sense do?
QT Sense focuses on advancing quantum sensing technology, particularly in biomedical applications, by creating innovative products that enhance the understanding of cellular dynamics.
Where is QT Sense headquartered?
QT Sense is headquartered in Groningen, Netherlands.
Which VCs invest in companies like QT Sense?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at QT Sense's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like QT Sense? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.